Tango Therapeutics, Inc.
TNGX •
Buy Open
Signal type
Buy
Status
Open
Open Price
$16.97
Stop Loss
$15.83
Performance
41.78%
Days Open
41
Signal Setup
Signal Type Buy
Status Open
Open Date Mar 5, 2026
Open Price $16.97
Stop Loss $15.83
Timespan Day
Company Profile
Name Tango Therapeutics, Inc.
Ticker TNGX
Market Cap $554.98M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $24.06
List Date Aug 11, 2021
Description
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Website Open Company Website